Global Neurological Biomarkers Market Set for Remarkable Growth, Poised to Reach USD 12.5 Billion by 2033

Posted on 2024-09-04 by Future Market Insights in Healthcare // 0 Comments

The global neurological biomarkers market is on a robust growth trajectory, driven by the increasing demand for precise diagnostic tools and effective treatment monitoring solutions for neurological disorders. Recent market analysis highlights a promising future for the sector, with a projected Compound Annual Growth Rate (CAGR) of 4.6% over the forecast period.

The neurological biomarkers market, valued at USD 8 billion in 2023, is anticipated to achieve a market value of USD 12.5 billion by 2033. This significant upward trajectory underscores the growing need for advanced diagnostic and monitoring solutions that cater to the complexities of neurological conditions.

Factors contributing to this growth include advancements in biomarker discovery and technology, rising prevalence of neurological disorders, and an increasing emphasis on personalized medicine. As the demand for accurate and efficient diagnostic tools intensifies, the neurological biomarkers market is positioned to play a crucial role in enhancing patient outcomes and revolutionizing the management of neurological diseases.

“The impressive growth forecast for the neurological biomarkers market reflects the critical advancements in diagnostic and monitoring technologies,” said FMI. “As we move towards more personalized and precise treatment approaches, the market’s expansion will be pivotal in addressing the challenges associated with neurological disorders.”

Key Market Drivers:

Rising Prevalence of Neurological Disorders: With the global increase in neurological conditions, there is a growing demand for early detection and personalized treatment, which neurological biomarkers can provide.
Research and Development Investments: Substantial investments in R&D and collaborations between pharmaceutical companies and research institutions are driving the discovery of new biomarkers and the development of advanced diagnostic technologies.
Regional Market Leaders: The U.S. is expected to account for a significant share of the global neurological biomarkers market, driven by its leading laboratories and scientists. Meanwhile, the Asia-Pacific region, particularly Japan and India, is predicted to hold the largest share, thanks to the launch of novel solutions and the development of methods that enable earlier diagnosis and improved prognoses.

Neurological Biomarkers Trends on the Rise: Uncover the Full Scope with Our In-Depth Report!

Competitive Landscape:

Key players in the neurological biomarkers market are focusing on product innovation and global expansion. Companies such as Quanterix, Qiagen, ADx NeuroSciences NV, Merck KGaA, and Thermo Fisher Scientific are actively engaged in launching new products and expanding their presence in emerging markets. These efforts are expected to significantly contribute to the market’s growth.

Recent Developments:

In August 2020, Johnson & Johnson Services, Inc. partnered with Enigma Biomedical Group to evaluate novel neuroimaging biomarkers for Alzheimer’s disease and other dementias.
In 2019, MC10 Inc. collaborated with the University of Rochester to develop novel digital biomarkers for central nervous system diseases.

Market Segmentation:

By Type: Genomics Biomarkers, Proteomics Biomarkers, Metabolomics Biomarkers, Imaging Biomarkers, Others.
By Application: Alzheimer’s Disease, Parkinson’s Disease, Huntington’s Disease, Schizophrenia, Depression, Multiple Sclerosis, Spinal Muscular Atrophy.
By End User: Research Organizations, Pharma & Biotech Companies, Clinical Diagnostics.
By Region: North America, Latin America, Asia Pacific, Middle East and Africa (MEA), Europe.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Matched content

Editor’s pick